Circular non-coding RNA ANRIL modulates ribosomal RNA maturation and atherosclerosis in humans

Research output: Contribution to journalJournal articleResearchpeer-review

  • Lesca M Holdt
  • Anika Stahringer
  • Kristina Sass
  • Garwin Pichler
  • Nils A Kulak
  • Wolfgang Wilfert
  • Alexander Kohlmaier
  • Andreas Herbst
  • Bernd H Northoff
  • Alexandros Nicolaou
  • Gabor Gäbel
  • Frank Beutner
  • Markus Scholz
  • Joachim Thiery
  • Kiran Musunuru
  • Knut Krohn
  • Mann, Matthias
  • Daniel Teupser

Circular RNAs (circRNAs) are broadly expressed in eukaryotic cells, but their molecular mechanism in human disease remains obscure. Here we show that circular antisense non-coding RNA in the INK4 locus (circANRIL), which is transcribed at a locus of atherosclerotic cardiovascular disease on chromosome 9p21, confers atheroprotection by controlling ribosomal RNA (rRNA) maturation and modulating pathways of atherogenesis. CircANRIL binds to pescadillo homologue 1 (PES1), an essential 60S-preribosomal assembly factor, thereby impairing exonuclease-mediated pre-rRNA processing and ribosome biogenesis in vascular smooth muscle cells and macrophages. As a consequence, circANRIL induces nucleolar stress and p53 activation, resulting in the induction of apoptosis and inhibition of proliferation, which are key cell functions in atherosclerosis. Collectively, these findings identify circANRIL as a prototype of a circRNA regulating ribosome biogenesis and conferring atheroprotection, thereby showing that circularization of long non-coding RNAs may alter RNA function and protect from human disease.

Original languageEnglish
JournalNature Communications
Volume7
Pages (from-to)12429
ISSN2041-1723
DOIs
Publication statusPublished - 19 Aug 2016
Externally publishedYes

    Research areas

  • Journal Article

ID: 184324592